P.J. Eugster

Discipline

Psychologie (3)

Type de document

Articles (11) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Catecholamines (7) Patients (6) Human beings (6) Patients (6) analyse (5) Neuropeptide Y (5) plasma (5) puits (4) métabolisme (4) effet (4) Control (4) Metabolites (4) Volunteers (4) Secretion (4) Metabolism (4) Mass spectrometry (4) Blood (4) Tandem mass spectrometry (4) Secretion (4) Metabolism (4) temps (durée) (3) âge (3) Diagnosis (3) Tumors (3) Time (3) Stability (3) Peptides (3) Noradrenaline (3) Heart beat (3) Diagnosis (3)

Documents écrit par P.J. Eugster (11) | parle de P.J. Eugster (0)

Tutorial review for peptide assays: An ounce of pre-analytics is worth a pound of cure.
J. Maurer et al. (1 sept. 2023)
Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals.
A. Tripyla et al.
Saxagliptin: A potential doping agent? A randomized, double-blinded, placebo-controlled, and crossover pilot study in young active men.
N. Bourdillon et al.
Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma.
P.J. Eugster et al. (1 sept. 2022)
Quantification of serotonin and eight of its metabolites in plasma of healthy volunteers by mass spectrometry.
P.J. Eugster et al. (10 août 2022)
Kinetics of neuropeptide Y, catecholamines, and physiological responses during moderate and heavy intensity exercises.
P.J. Eugster et al.
Multiplexed Assay to Quantify the PP-Fold Family of Peptides in Human Plasma Using Microflow Liquid Chromatography-Tandem Mass Spectrometry.
G. Reverter-Branchat et al. (31 mars 2022)
Brain fog in neuropathic postural tachycardia syndrome may be associated with autonomic hyperarousal and improves after water drinking.
B. Rodriguez et al. (2022)
Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension.
A. Mühlethaler-Mottet et al. (2022)
Stabilization of urinary biogenic amines measured in clinical chemistry laboratories.
P.J. Eugster et al.
Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) During RAAS Inhibition.
J.R. Wilson et al. (1 oct. 2019)